相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized clinical trial: effect of low-dose flutamide on abdominal adipogenic function in normal-weight women with polycystic ovary syndrome
Daniel A. Dumesic et al.
FERTILITY AND STERILITY (2023)
Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: A systematic review
Maria Forslund et al.
CLINICAL ENDOCRINOLOGY (2023)
Update on PCOS: Consequences, Challenges, and Guiding Treatment
Kathleen M. Hoeger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
Francis de Zegher et al.
SCIENTIFIC REPORTS (2021)
Harmonising research outcomes for polycystic ovary syndrome: an international multi-stakeholder core outcome set
Bassel H. Al Wattar et al.
HUMAN REPRODUCTION (2020)
Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome
Lourdes Ibanez et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2020)
Towards a circulating marker of hepato-visceral fat excess: S100A4 in adolescent girls with polycystic ovary syndrome Evidence from randomized clinical trials
Rita Malpique et al.
PEDIATRIC OBESITY (2019)
Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double- Blind Randomized Controlled Trial
Costanzo Moretti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis
Patricia Barrionuevo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome
Marta Diaz et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial
Macarena Alpanes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome
Lourdes Ibanez et al.
JOURNAL OF ADOLESCENT HEALTH (2017)
Differential Effects on Haemostatic Markers by Metformin and the Contraceptive Pill: A Randomized Comparative Trial in PCOS
Genia F. Burchall et al.
THROMBOSIS AND HAEMOSTASIS (2017)
COMPARISON OF FINASTERIDE, METFORMIN, AND FINASTERIDE PLUS METFORMIN IN PCOS
H. Diri et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2017)
Single-Paper Meta-Analysis: Benefits for Study Summary, Theory Testing, and Replicability
Blakeley B. McShane et al.
JOURNAL OF CONSUMER RESEARCH (2017)
Androgen excess: Investigations and management
Dania Lizneva et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2016)
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
Robert L. Rosenfield et al.
ENDOCRINE REVIEWS (2016)
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis
Gurkan Bozdag et al.
HUMAN REPRODUCTION (2016)
Polycystic ovary syndrome
Ricardo Azziz et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Choosing a combined oral contraceptive pill
Mary Stewart et al.
AUSTRALIAN PRESCRIBER (2015)
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis
Negar Naderpoor et al.
HUMAN REPRODUCTION UPDATE (2015)
The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
Y. Zimmerman et al.
HUMAN REPRODUCTION UPDATE (2014)
Intermittent Low-Dose Finasteride Administration Is Effective for Treatment of Hirsutism in Adolescent Girls: A Pilot Study
Mario V. Tartagni et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2014)
In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone
A. Mazza et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Bicalutamide-induced hepatotoxicity: A rare adverse effect
Salwa Hussain et al.
AMERICAN JOURNAL OF CASE REPORTS (2014)
Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community
George A. Asare et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2014)
Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
Mohd Ashraf Ganie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome
Carolina Sales Vieira et al.
CONTRACEPTION (2012)
GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Treatment options for polycystic ovary syndrome
Ahmed Badawy et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2011)
Hirsutism: Evaluation and treatment
Silonie Sachdeva
INDIAN JOURNAL OF DERMATOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Ricardo Azziz et al.
FERTILITY AND STERILITY (2009)
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
Yu Chen et al.
LANCET ONCOLOGY (2009)
A systematic review of commonly used medical treatments for hirsutism in women
Olympia Koulouri et al.
CLINICAL ENDOCRINOLOGY (2008)
Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome
Caroline Meyer et al.
DIABETES CARE (2007)
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: A randomized, 12-month, placebo-controlled study
Alessandra Gambineri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Metformin and weight loss in obese women with polycystic ovary syndrome: Comparison of doses
LR Harborne et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism:: Opposite effects on adipocytokines and body adiposity
L Ibáñez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: An open-labeled study
MA Ganie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Spironolactone as a single agent for long-term therapy of hirsute patients
PM Spritzer et al.
CLINICAL ENDOCRINOLOGY (2000)
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
M Tartagni et al.
FERTILITY AND STERILITY (2000)
分享论文
